RTB101

DRUG2 trials

Sponsors

Restorbio Inc.

Conditions

COVID19Covid19

Phase 2

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

TerminatedNCT04409327

Restorbio Inc.COVID19

Start: 2020-07-11End: 2021-01-24Updated: 2021-02-10

A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

Active, not recruitingNCT04584710

Restorbio Inc.Covid19

Start: 2020-10-13End: 2021-02-28Target: 60Updated: 2021-02-09